Trilafon effects

Perphenazine (Trilafon). Perphenazine has a potency and side effect profile similar to other medium potency antipsychotics. 

Despite enormous hype to the contrary, it soon became apparent that these newer medications were no less harmful than the older ones. Studies showing a lower rate of adverse effects simply used comparatively lower doses (Smith, 2001). Given that these drugs are neither safer nor more effective than older drugs like perphenazine (Trilafon see the subsequent sections), and given that they cost a great deal more (Rosenheck et ah, 2006), this was another triumph of pharmaceutical marketing. 

Note that perphenazine (Trilafon) is in the middle of the pack there was no statistical difference between it and the leader, olanzapine (Zy-prexa). But Zyprexa had the worst adverse effect profile (see subsequent sections). 

The piperzine group produces a low sedative effect and a strong antiemetic effect, more EPS, and little effect on blood pressure. Included in this group are prochlorperazine (Compazine), fluphenazine (Prolixin), perphenazine (Trilafon), and trifluoperazine (Stelazine). 

---